Pharmaceuticals decks.
6 decks from pharmaceuticals companies, best reviewed first.

Novo Nordisk A/S investor presentation, Q3 2026 investor presentation
The deck opens with a title slide, an agenda and a forward-looking statements disclaimer, then moves into a Q3 2026 highlights page on the 2030 ambitions.

Merck & Co., Inc. investor presentation, Third-Quarter 2026 Sales and Earnings
The deck opens with a title slide and an agenda naming four speakers: the chairman and CEO, the CFO, and the head of research, followed by a Q&A.

Pfizer investor presentation, Third Quarter 2026 earnings
The deck is the slide set used for Pfizer's third quarter 2026 earnings teleconference on November 3, 2026.

Merck & Co. (MSD outside the US and Canada) course deck, 2024
This is a healthcare professional education deck from MSD Oncology about KEYNOTE-189, a Phase 3 trial of KEYTRUDA (pembrolizumab) plus chemotherapy as first-line treatment for metastatic non-squamous NSCLC.

Merck & Co., Inc. conference talk, 2026
The deck opens with a title slide for Merck's presentation at the JP Morgan Healthcare Conference, followed by a Business and Pipeline Update delivered by the Chairman and Chief Executive Officer, and a forward-looking statement disclaimer.

Novartis investor presentation, 2026
The deck is Novartis's Q3 2026 results investor presentation, dated October 27, 2026, and presented by CEO Vas Narasimhan and CFO Mukul Mehta.